Skip to main content
Clinical Trials/NCT03823209
NCT03823209
Active, not recruiting
Not Applicable

Increasing PrEP Use in High-Risk Social Networks of African-American MSM in Underserved Low-Risk Cities

Medical College of Wisconsin2 sites in 1 country500 target enrollmentJanuary 24, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Human Immunodeficiency Virus
Sponsor
Medical College of Wisconsin
Enrollment
500
Locations
2
Primary Endpoint
Self-report of pre-exposure prophylaxis (PrEP) use
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

This study evaluates the use of a social-network approach to encourage African-American men who have sex with men (AAMSM) to adopt pre-exposure prophylaxis (PrEP) to prevent HIV infection. Thirty-six networks of AAMSM will be recruited in Milwaukee, WI, and Cleveland, OH. Half of these networks will have their leaders trained to endorse PrEP to their social network members, and the other half will be given brief HIV prevention counseling.

Detailed Description

Pre-exposure prophylaxis (PrEP) regimens greatly reduce the likelihood that high-risk uninfected men who have sex with men (MSM) will contract HIV infection. Although this protective benefit has been unequivocally established in clinical trials, the number of high-risk men on PrEP remains far below the threshold needed to substantially reduce HIV incidence. This is especially true outside of the country's largest cities. Novel approaches are needed to increase PrEP use among high-risk racial minority MSM in these neglected cities. This study will recruit 36 sociocentric social networks of high-risk young racial minority MSM, 18 networks per city (total n=36 networks x 14 anticipated recruited members per network = 504 participants). Participants will complete measures assessing baseline PrEP use; knowledge, attitudes, perceived norms, intentions, and stage of readiness for PrEP; sexual risk practices and substance use; and prior or current ART use. Participants will also complete measures used to identify each network's leaders. Networks will be randomized in equal numbers in each city to comparison or intervention conditions. All study participants will receive individual baseline counseling about risk reduction and PrEP, with referral offered to clinics prescribing PrEP. Members of the 18 experimental condition networks will also receive the social network PrEP intervention being tested in the study. In it, cadres of leaders in each network-selected based on their leadership position within the network and their own openness to PrEP-will attend a 5-session intervention that trains, engages, and supports network leaders in communicating to friends accurate information about PrEP and its availability; corrects PrEP misconceptions and negative stereotypes; endorses PrEP use and its benefits; and strengthens friends' attitudes, intentions, perceived peer norms, and self-efficacy regarding PrEP as a personal HIV protective strategy. Two additional booster sessions spaced monthly will support maintenance of leaders' efforts in talking with friends in their network about the benefits of PrEP, as well as where and how to access it. At 6- and 15-month followup points, all study participants will complete the same behavioral measures that were administered at baseline, as well as measures of intervention exposure.

Registry
clinicaltrials.gov
Start Date
January 24, 2019
End Date
December 1, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jeffrey Kelly

Professor

Medical College of Wisconsin

Eligibility Criteria

Inclusion Criteria

  • INDIVIDUALS:
  • Age 16 or older
  • For the seed only, self-report of HIV-negative serostatus or unknown serostatus
  • Except for the seed, being named as a friend by an already-enrolled participant
  • Male at birth
  • Sex with at least one male partner in the past 12 months
  • More than 49% of the seed's eligible friends agree to participate
  • More than 49% of all network members self-report they are HIV-negative at baseline

Exclusion Criteria

  • INDIVIDUALS:
  • Age 15 or younger
  • For the seed only, self-report of HIV-positive serostatus
  • Except for the seed, not being named as a friend by an already-enrolled participant
  • Not male at birth
  • No report of sex with at least one male partner in the past 12 months
  • Less than 50% of the seed's eligible friends agree to participate
  • Less than 50% of all network members self-report they are HIV-negative at baseline

Outcomes

Primary Outcomes

Self-report of pre-exposure prophylaxis (PrEP) use

Time Frame: 6 and 15 months

Change in self-reported PrEP use

Secondary Outcomes

  • Pre-Exposure Prophylaxis (PrEP) Knowledge(6 and 15 months)
  • Pre-Exposure Prophylaxis Norm Perceptions(6 and 15 months)
  • Pre-Exposure Prophylaxis Attitudes(6 and 15 months)
  • Pre-Exposure Prophylaxis Intentions(6 and 15 months)
  • Pre-Exposure Prophylaxis Self-Efficacy(6 and 15 months)

Study Sites (2)

Loading locations...

Similar Trials